Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction

被引:107
|
作者
Valentino, Rita J. [1 ]
Lucki, Irwin [2 ]
Van Bockstaele, Elisabeth [3 ]
机构
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
关键词
Serotonin; Dorsal raphe nucleus; Corticotropin-releasing factor; Stress; Receptor trafficking; Drug abuse; VESICULAR GLUTAMATE TRANSPORTERS; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; FORCED SWIMMING TEST; HUMAN BRAIN-STEM; ALCOHOL INTAKE; RAT-BRAIN; EXTRACELLULAR; 5-HYDROXYTRYPTAMINE; 5-HYDROXYINDOLEACETIC ACID; BEHAVIORAL CONSEQUENCES;
D O I
10.1016/j.brainres.2009.09.100
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Addiction and stress are linked at multiple levels. Drug abuse is often initiated as a maladaptive mechanism for coping with stress. It is maintained in part by negative reinforcement to prevent the aversive consequences of stress associated with abstinence. Finally, stress is a major factor leading to relapse in subjects in which drug seeking behavior has extinguished. These associations imply overlapping or converging neural circuits and substrates that underlie the processes of addiction and the expression of the stress response. Here we discuss the major brain serotonin (5-HT) system, the dorsal raphe nucleus (DRN)-5-HT system as a point of convergence that links these processes and how the stress-related neuropeptide, corticotropin-releasing factor (CRF) directs this by a bimodal regulation of DRN neuronal activity. The review begins by describing a structural basis for CRF regulation of the DRN-5-HT system. This is followed by a review of the effects of CRF and stress on DRN function based on electrophysiological and microdialysis studies. The concept that multiple CRF receptor subtypes in the DRN facilitate distinct coping behaviors is reviewed with recent evidence for a unique cellular mechanism by which stress history can determine the type of coping behavior. Finally, work on CRF regulation of the DRN-5-HT system is integrated with literature on the role of S-HT-dopamine interactions in addiction. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 37
页数:9
相关论文
共 50 条
  • [41] Stress, corticotropin-releasing factor and cognitive flexibility
    Chaijale, Nayla
    Snyder, Kevin
    Wang, Wei-Wen
    Bhatnagar, Seema
    Valentino, Rita
    FASEB JOURNAL, 2011, 25
  • [42] CORTICOTROPIN-RELEASING FACTOR - FROM STRESS TO COGNITION
    LIGHTMAN, SL
    NATURE, 1995, 378 (6554) : 233 - 234
  • [43] The amygdala: Corticotropin-releasing factor, steroids, and stress
    Gray, TS
    Bingaman, EW
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1996, 10 (02): : 155 - 168
  • [44] CORTICOTROPIN-RELEASING FACTOR
    YASUDA, N
    GREER, MA
    AIZAWA, T
    ENDOCRINE REVIEWS, 1982, 3 (02) : 123 - 140
  • [45] CORTICOTROPIN-RELEASING FACTOR
    JENNES, L
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1990, 597 : 231 - 238
  • [46] THE CORTICOTROPIN-RELEASING FACTOR
    CONTEDEVOLX, B
    OLIVER, C
    REY, M
    GUILLAUME, V
    CASTANAS, E
    GIRAUD, P
    BOUDOURESQUE, F
    GRINO, M
    PRESSE MEDICALE, 1985, 14 (13): : 737 - 741
  • [47] Allostasis and addiction: Role of the dopamine and corticotropin-releasing factor systems
    George, Olivier
    Le Moal, Michel
    Koob, George F.
    PHYSIOLOGY & BEHAVIOR, 2012, 106 (01) : 58 - 64
  • [48] CORTICOTROPIN-RELEASING FACTOR
    DUNTAS, L
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (19) : 794 - 794
  • [49] HUMAN PLACENTAL CORTICOTROPIN-RELEASING FACTOR IS IDENTICAL TO HYPOTHALAMIC CORTICOTROPIN-RELEASING FACTOR
    STALLA, GK
    BOST, H
    KALIEBE, T
    HUBER, M
    STALLA, J
    PFEIFFER, D
    VONWERDER, K
    MULLER, OA
    ACTA ENDOCRINOLOGICA, 1986, 111 : 169 - 169
  • [50] Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus (vol 220, pg 599, 2012)
    Tanahashi, Shunsuke
    Yamamura, Satoshi
    Nakagawa, Masanori
    Motomura, Eishi
    Okada, Motohiro
    PSYCHOPHARMACOLOGY, 2021, 238 (01) : 323 - 323